Literature DB >> 18177398

Keloids and hypertrophic scars: are they two different sides of the same coin?

Osman Köse1, Ahmad Waseem.   

Abstract

Keloids and hypertrophic scars are different forms of excessive dermal fibrosis thought to be caused by regulation of cellularity increase and decrease during the wound-healing process in predisposed individuals. Differences between keloids and hypertrophic scars include distinct clinical features, histologic evidence, and cellular function in response to molecular events. Keloids and hypertrophic scars are the results of increased fibroblast density and extracellular matrix substances. Interactions between epidermal keratinocytes and dermal fibroblasts play an important role in regulating tissue homeostasis and processing scar formation. Keloids and hypertrophic scars are the two different stages of the same process that is based on separate clinical and histochemical entities. The aim of this review is to provide updated information regarding similarities and differences between keloids and hypertrophic scars as two different sides of the same coin. This article will also enable the dermatologist to better understand fundamental biology of the scarring.

Entities:  

Mesh:

Year:  2007        PMID: 18177398     DOI: 10.1111/j.1524-4725.2007.34067.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  30 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 2.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

3.  Unfolded protein response regulation in keloid cells.

Authors:  Paris D Butler; Zhen Wang; Daphne P Ly; Michael T Longaker; Albert C Koong; George P Yang
Journal:  J Surg Res       Date:  2009-05-20       Impact factor: 2.192

4.  Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds.

Authors:  Piyush Koria; Hiroshi Yagi; Yuko Kitagawa; Zaki Megeed; Yaakov Nahmias; Robert Sheridan; Martin L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-30       Impact factor: 11.205

5.  Hydration status regulates sodium flux and inflammatory pathways through epithelial sodium channel (ENaC) in the skin.

Authors:  Wei Xu; Seok Jong Hong; Michael Zeitchek; Garry Cooper; Shengxian Jia; Ping Xie; Hannan A Qureshi; Aimei Zhong; Marshall D Porterfield; Robert D Galiano; D James Surmeier; Thomas A Mustoe
Journal:  J Invest Dermatol       Date:  2014-11-05       Impact factor: 8.551

6.  A Mechanomodulatory Device to Minimize Incisional Scar Formation.

Authors:  Victor W Wong; Bill Beasley; John Zepeda; Reinhold H Dauskardt; Paul G Yock; Michael T Longaker; Geoffrey C Gurtner
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-05       Impact factor: 4.730

7.  Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.

Authors:  Qing Chun; Wang ZhiYong; Song Fei; Wang XiQiao
Journal:  Int Wound J       Date:  2014-05-07       Impact factor: 3.315

8.  The Relationship between Proliferative Scars and Endothelial Function in Surgically Revascularized Patients.

Authors:  Murat Ziyrek; Sinan Şahin; Zeydin Acar; Onur Şen
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

9.  Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts.

Authors:  Bruna De Felice; Corrado Garbi; Margherita Santoriello; Alessandra Santillo; Robert R Wilson
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

10.  Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars.

Authors:  Victor W Wong; Fanglei You; Michael Januszyk; Geoffrey C Gurtner; Anna A Kuang
Journal:  Ann Plast Surg       Date:  2014       Impact factor: 1.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.